HIGHLIGHTS
- who: Hiu Ting Chan and collaborators from the Cancer Precision Medicine, Inc, Kawasaki, Japan have published the research: Circulating Tumor DNA-Based Genomic Profiling Assays in Adult Solid Tumors for Precision Oncology: Recent Advancements and Future Challenges, in the Journal: Cancers 2022, 14, 3275. of /2022/
- what: The authors provide the perspectives on the key challenges that should be attended to optimize the use of ctDNA-based CGP in oncology management.
- future: Future studies should focus on expanding the current roles of plasma ctDNA to improve patient access to precision medicine and thereby . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.